申请人:ACTELION PHARMACEUTICALS LTD
公开号:US20160075722A1
公开(公告)日:2016-03-17
The invention relates to antibacterial compounds of formula I (I) wherein R is H, cyano, alkoxy, cyanomethoxy, cycloalkylmethoxy, hydroxyalkoxy, alkoxyalkoxy, alkoxycarbonyl, 2-ethoxy-2-oxoethoxy, 2-(methylamino)-2-oxoethoxy, (1-cyanocyclobutyl)methoxy, 3-hydroxy-pyrrolidin-1-yl or 3,4-dihydroxycyclopentyl)methoxy; U
1
is N or CR
1
, U
2
is N or CR
1
, U
3
is N or CR
3
and U
4
is N or CR
1
, it being understood that at most three of U
1
, U
2
, U
3
and U
4
can be N at the same time; V
1
is N or CR
5
, V
2
is N or CR
6
, V
3
is N or CR
7
and V
4
is N or CH, it being understood that at most two of V
1
, V
2
, V
3
and V4 can be N at the same time; R1 is H, cyano, hydroxy or alkoxy; R2 is H, hydroxy or alkoxy; R
3
is H, cyano, hydroxy, alkoxy or carboxamido; R
4
is H or alkoxy; R
5
is H, hydroxy or halogen; R
6
is H, hydroxy or halogen; R
7
is H; the dotted line “______” represents a bond or is absent; W represents CH or N when the dotted line “______” is a bond, or W represents CH
2
when the dotted line “______” is absent; X represents CH or N; and Q represents O or S; and salts thereof.
本发明涉及式I的抗菌化合物(I),其中R为H,氰基,烷氧基,氰甲氧基,环烷基甲氧基,羟基烷氧基,烷氧基烷氧基,烷氧基羧酰基,2-乙氧基-2-氧代乙氧基,2-(甲基氨基)-2-氧代乙氧基,(1-氰基环丁基)甲氧基,3-羟基吡咯烷-1-基或3,4-二羟基环戊基)甲氧基;U1为N或CR1,U2为N或CR1,U3为N或CR3,U4为N或CR1,其中最多只能同时有三个U1,U2,U3和U4为N;V1为N或CR5,V2为N或CR6,V3为N或CR7,V4为N或CH,其中最多只能同时有两个V1,V2,V3和V4为N;R1为H,氰基,羟基或烷氧基;R2为H,羟基或烷氧基;R3为H,氰基,羟基,烷氧基或羧酰胺基;R4为H或烷氧基;R5为H,羟基或卤素;R6为H,羟基或卤素;R7为H;虚线“______”表示键或不存在;当虚线“______”为键时,W表示CH或N,当虚线“______”不存在时,W表示CH2;X表示CH或N;Q表示O或S;以及其盐。